Agios Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANAB
|
AnaptysBio, Inc. | $33.99 | $640.07 M | -3.82 | 117 | $17.16 M |
 ARVN
|
Arvinas, Inc. | $24.95 | $1.83 B | -4.41 | 445 | $78.50 M |
 BDTX
|
Black Diamond Therapeutics, Inc. | $3.75 | $291.95 M | -3.13 | 54 | $0 |
 BMRN
|
BioMarin Pharmaceutical Inc. | $69.50 | $15.32 B | 76.12 | 3401 | $2.42 B |
 BPMC
|
Blueprint Medicines Corporation | $88.58 | $6.47 B | -21.48 | 638 | $249.38 M |
 CCCC
|
C4 Therapeutics, Inc. | $5.40 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.32 | $1.29 B | -7.16 | 85 | $0 |
 COGT
|
Cogent Biosciences, Inc. | $11.09 | $802.20 M | -3.37 | 164 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.10 | $1.12 B | -5.11 | 169 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 IDYA
|
IDEAYA Biosciences, Inc. | $29.97 | $2.88 B | -19 | 124 | $23.39 M |
 KALV
|
KalVista Pharmaceuticals, Inc. | $11.35 | $492.76 M | -3.74 | 150 | $0 |
 KROS
|
Keros Therapeutics, Inc. | $61.06 | $1.76 B | -9.45 | 149 | $151,000 |
 KYMR
|
Kymera Therapeutics, Inc. | $42.73 | $2.02 B | -13.13 | 181 | $78.59 M |
 MGTX
|
MeiraGTx Holdings plc | $4.14 | $306.74 M | -4.01 | 387 | $14.02 M |
 MREO
|
Mereo BioPharma Group plc | $4.40 | $479.72 M | -22.8 | 33 | $10.00 M |
 MRSN
|
Mersana Therapeutics, Inc. | $2.12 | $261.85 M | -1.91 | 123 | $36.86 M |
 NRIX
|
Nurix Therapeutics, Inc. | $22.17 | $930.10 M | -5.89 | 284 | $76.99 M |
 PLRX
|
Pliant Therapeutics, Inc. | $11.53 | $672.63 M | -3.9 | 166 | $1.58 M |
 RLAY
|
Relay Therapeutics, Inc. | $6.54 | $1.05 B | -3 | 304 | $25.55 M |
 RVMD
|
Revolution Medicines, Inc. | $47.31 | $6.66 B | -10.51 | 443 | $11.58 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.82 | $1.66 B | -6.02 | 184 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $11.72 | $774.50 M | -6.14 | 110 | $8.78 M |